Revvity (RVTY) P/E (2010 - 2026)
Revvity (RVTY) P/E from Apr 5, 2010 to Jul 21, 2026. The TTM Revvity (RVTY) P/E is 52.29. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Revvity (RVTY)
| Year | P/E | Change |
|---|---|---|
| 2026 | 52.29 | +13.64% |
| 2025 | 46.01 | -8.61% |
| 2024 | 50.35 | +171.47% |
| 2023 | 18.55 | -33.80% |
| 2022 | 28.01 | +39.13% |
| 2021 | 20.14 | -48.19% |
| 2020 | 38.86 | -18.00% |
| 2019 | 47.39 | +29.57% |
| 2018 | 36.58 | +81.15% |
| 2017 | 20.19 | -16.40% |
| 2016 | 24.15 | -30.01% |
| 2015 | 34.51 | +10.32% |
| 2014 | 31.28 | +12.97% |
| 2013 | 27.69 | -46.48% |
| 2012 | 51.74 | +760.86% |
| 2011 | 6.01 | -81.13% |
| 2010 | 31.85 | N/A |
Comparison Revvity (RVTY) P/E with competitors
Revvity (RVTY) P/E is 52.29.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -97.99% |
| MBAI | CheckCap Ltd | 1.71 | -96.72% |
| FONR | Fonar Corp | 15.48 | -70.40% |
| QGEN | Qiagen NV | 20.03 | -61.69% |
| DGX | Quest Diagnostics Inc | 22.47 | -57.02% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -54.35% |
| IQV | IQVIA Holdings Inc | 25.28 | -51.65% |
| A | Agilent Technologies Inc | 26.96 | -48.44% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -39.70% |
| MTD | Mettler-Toledo International Inc | 32.45 | -37.94% |
| MEDP | Medpace Holdings Inc | 32.55 | -37.75% |
| DHR | Danaher Corp | 38.55 | -26.27% |
| IDXX | Idexx Laboratories Inc | 40.58 | -22.40% |
| ILMN | Illumina Inc | 44.12 | -15.62% |
| VCYT | Veracyte Inc | 53.71 | +2.72% |
| ICLR | Icon Plc | 57.45 | +9.87% |
| SHC | Sotera Health Company | 74.08 | +41.68% |
| WAT | Waters Corp | 102.79 | +96.57% |